Doxazosin Tablet
Product Images NDC 70518-1560

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 70518-1560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin 2mg 70518 1560 01

Label for Doxazosin 2 mg oral tablets, quantity of 90, repackaged by Remedy Repack Inc. The label includes directions to see the package insert, storage instructions (20-25°C with permitted excursions 15-30°C), and manufacturing information by Accord Healthcare, Inc. in Durham, NC. The product is prescription only and includes a QR code.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Doxazosin 2 mg oral tablets by Remedy Repack Inc., containing 30 tablets. The label displays the product name, strength, dosage form, quantity, and manufacturer details including NDC number 70518-1560-00. It includes storage instructions and states the product is prescription only (RX only).*

FDA Label Image

Table 1 (Doxazosin Fig1)

A table summarizing effectiveness data from three placebo-controlled studies comparing symptom scores and maximum flow rate changes in patients treated with Doxazosin versus placebo. The table includes baseline symptom scores, mean changes, and maximum flow rates, alongside a bar chart visually comparing placebo and Doxazosin doses of 4 mg and 8 mg for symptom score and maximum flow rate changes.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Two line graphs showing clinical study results comparing Doxazosin and placebo over 14 weeks. The left graph depicts mean change in total symptom score from baseline, with Doxazosin showing greater symptom improvement. The right graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline, with Doxazosin demonstrating higher flow rate increase compared to placebo.*

FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical structure of Doxazosin mesylate, illustrating its molecular composition with characteristic rings and functional groups as labeled.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.